This website uses cookies to ensure you have the best user experience. By continuing to use this website, you consent to our use of cookies. For more information, read our privacy policy.
Engaging Indigenous Communities to Understand Perspectives on Genetic Testing and Risk-Reducing Surgery for Ovarian Cancer in Alberta, Canada
Deciphering phosphorylation-dependent signal rewiring in ovarian and endometrial cancer
Patient-centred Hereditary Ovarian Cancer Prevention and Survivorship Care in Canada
Precision medicine for patients with co-existent ovarian and endometrial cancer: the COMPARE trial
Metabolic engineering of CAR-T cells to overcome immune suppression
Remodeling the immune microenvironment of ovarian cancer using oncolytic viruses
Understanding how glycosylated antitumour ether lipids (GAELs) kill chemotherapy-resistant cancer cells
Investigating the “surfaceome” to discover new treatments for rare ovarian cancers
Understanding and targeting single-stranded DNA gap-filling mechanisms to improve chemotherapy response
Exploring a new therapeutic approach for rare ovarian cancers
